Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -23.08% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 37 | 11/04/21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 12/04/21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 10/12/17 |
Tony Fiorino
BRD | Director/Board Member | 56 | 14/08/17 |
Boris Shor
PRN | Corporate Officer/Principal | - | - |
John P. Clark
AUD | Comptroller/Controller/Auditor | 52 | 19/11/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 14/08/17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 01/02/16 |
Daniel Kazado
BRD | Director/Board Member | 59 | 09/10/13 |
Jeff Paley
BRD | Director/Board Member | 55 | 22/02/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 3,713 | 0 | 0 | 100.00 % |
Stock B | 1 | 172,878,093 | 172,878,093 ( 100.00 %) | 0 |
Company contact information
Immune Pharmaceuticals, Inc.
1 Bridge Plaza North Suite 270
07024, Englewood Cliffs
+201-464-2677
http://www.immunepharma.comSector
1st Jan change | Capi. | |
---|---|---|
+26.47% | 664B | |
+24.91% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+14.09% | 234B | |
+4.60% | 199B | |
-9.73% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- FZRQ Stock
- IMNPQ Stock
- Company Immune Pharmaceuticals, Inc.